Clinical Trial Update: Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treosulfan-based conditioning for hematopoietic stem cell transplantation in Nijmegen Breakage Syndrome; currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nijmegen Breakage Syndrome

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: HSCT, Nijmegen Breakage Syndrome | Phase 2 | Status: NOT_YET_RECRUITING